Allosteric Regulation in Multimeric Enzymes: Biophysical Mechanisms and Biomedical Applications

Background: Allosteric regulation is a fundamental principle of enzymatic control whereby binding of an effector molecule at a site distinct from the active site induces conformational changes that modulate catalytic activity. This phenomenon is particularly prominent in multimeric enzymes, where inter-subunit communication enables fine-tuned responses to metabolic cues, signaling molecules, or environmental changes. Understanding the structural and dynamic basis of allosteric modulation in multimeric systems is crucial for unraveling complex biological regulation and for designing therapeutics that exploit these mechanisms. Methods and Results: This review synthesizes recent advances in biophysical techniques—including cryo-electron microscopy, nuclear magnetic resonance spectroscopy, single-molecule Förster resonance energy transfer, and hydrogen-deuterium exchange mass spectrometry—that have enabled atomic-level characterization of allosteric transitions in multimeric enzymes. We highlight canonical models of cooperativity, such as the Monod-Wyman-Changeux and Koshland-Némethy-Filmer frameworks, and extend these paradigms to dynamic, asymmetric, and non-equilibrium systems. Biomedical applications of allostery include the development of selective enzyme modulators, allosteric inhibitors, and activators that offer advantages over orthosteric drugs in terms of specificity, reduced toxicity, and tunable regulation. Emerging computational and machine learning approaches are facilitating the prediction of allosteric sites and the rational design of modulators with enhanced efficacy. Conclusion: Allosteric regulation in multimeric enzymes represents a powerful, evolutionarily conserved mechanism for controlling enzymatic function across biological systems. Integrating structural, kinetic, and computational insights into allostery is paving the way for innovative therapeutic strategies that leverage conformational plasticity for targeted intervention in complex diseases.